Pharsight

Omeprazole patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023391 DEXCEL PHARMA Stable benzimidazole formulation
Aug, 2025

(1 year, 2 months from now)

Omeprazole is owned by Dexcel Pharma.

Omeprazole contains Omeprazole.

Omeprazole has a total of 1 drug patent out of which 0 drug patents have expired.

Omeprazole was authorised for market use on 04 December, 2007.

Omeprazole is available in tablet, delayed release;oral dosage forms.

The generics of Omeprazole are possible to be released after 16 August, 2025.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using OMEPRAZOLE ingredient

Market Authorisation Date:

04 December, 2007

Treatment:

NA

Dosage:

TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

OMEPRAZOLE family patents

Family Patents
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10835488 DEXCEL Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(12 years from now)

US10076494 DEXCEL Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(12 years from now)

Omeprazole is owned by Dexcel.

Omeprazole contains Omeprazole.

Omeprazole has a total of 2 drug patents out of which 0 drug patents have expired.

Omeprazole was authorised for market use on 05 July, 2017.

Omeprazole is available in tablet, orally disintegrating, delayed release;oral dosage forms.

The generics of Omeprazole are possible to be released after 08 December, 2036.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using OMEPRAZOLE ingredient

Market Authorisation Date:

05 July, 2017

Treatment:

NA

Dosage:

TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage

OMEPRAZOLE family patents

Family Patents